Indirect treatment comparison of brigatinib versus alectinib for first-line treatment of ALK-positive non-small-cell lung cancer

M Thomas, C Grohe, Christiane Waller, B Ratsch, E Basic, W Bruckl

Research output: Contribution to journal › published Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	153-154
Journal	Oncology Research and Treatment
Volume	43
Issue number	SUPPL 4
Publication status	Published - 2020

Access to Document

@article{135f4cf77ad94c78aeac131bf2db7ea6,

title = "Indirect treatment comparison of brigatinib versus alectinib for first-line treatment of ALK-positive non-small-cell lung cancer",

author = "M Thomas and C Grohe and Christiane Waller and B Ratsch and E Basic and W Bruckl",

year = "2020",

language = "English",

volume = "43",

pages = "153--154",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

number = "SUPPL 4",

}

TY - JOUR

T1 - Indirect treatment comparison of brigatinib versus alectinib for first-line treatment of ALK-positive non-small-cell lung cancer

AU - Thomas, M

AU - Grohe, C

AU - Waller, Christiane

AU - Ratsch, B

AU - Basic, E

AU - Bruckl, W

PY - 2020

Y1 - 2020

M3 - published Abstract (Journal)

SN - 2296-5270

VL - 43

SP - 153

EP - 154

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - SUPPL 4

ER -